Importantly, the data here provide a mechanistic rationale for the concurrent induction of NLRP3 inflammasome–enabled caspase-1 activation, myeloid skewing, and the competitive renewal advantage of clonal HSPCs in the inflammatory MDS microenvironment. This evidence concerns the gene CASP1 and myelodysplastic syndrome.